| Analysis | Metabolite Name | Measured Value | Units | Treatment | Tissue Type |
|---|---|---|---|---|---|
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 23.4 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 23.8 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 26.9 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 28 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 28 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 28.1 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 29.3 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 30.8 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 31.3 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 32.9 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 34.8 | nM | LFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 39.3 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 40.3 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 41.2 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 46.6 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 48.3 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 69.5 | nM | SW | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 113 | nM | HFD | Plasma |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 588 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 663 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 674 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 699 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 717 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 783.5 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 873 | nM | LFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 939 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 973 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1060 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1070 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1190 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1230 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1340 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1360 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1400 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1430 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1480 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1600 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1630 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1670 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1680 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1710 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1790 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1850 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1860 | nM | LFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1860 | nM | SW | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1880 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1920 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1960 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2050 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2070 | nM | HFD | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2510 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2740 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2970 | nM | SW | Liver |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 3860 | nM | HFD | Adipose |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 6270 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 6360 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 6820 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 7490 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 7510 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 7730 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 7760 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 8510 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 9010 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 9350 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 9360 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 10795 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 11000 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 11215 | nM | LFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 11645 | nM | HFD | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 12000 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 12700 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 14500 | nM | SW | Muscle |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1090000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1100000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1300000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1350000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1450000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1450000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1490000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1770000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1780000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1800000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1890000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 1920000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2050000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2280000 | nM | HFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2330000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 2360000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 3110000 | nM | SW | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | 3720000 | nM | LFD | Hypothalmus |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | HFD | Adipose | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | HFD | Hypothalmus | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | HFD | Liver | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | HFD | Muscle | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | HFD | Plasma | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | LFD | Adipose | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | LFD | Hypothalmus | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | LFD | Liver | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | LFD | Muscle | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | LFD | Plasma | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | SW | Adipose | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | SW | Hypothalmus | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | SW | Liver | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | SW | Muscle | |
| ESI positive ion mode (Ceramide analysis) | C18 Ceramide | nM | SW | Plasma |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|